United States

Analyst Research Report Snapshot


Merck & Co., Inc.






04 Aug 2015





Companies referenced:


Available for Immediate Download

Merck & Co., Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Merck & Co., Inc. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Merck & Co., Inc. in the form of a SWOT analysis - An in-depth view of the business model of Merck & Co., Inc. including a breakdown and examination of key business segments - Intelligence on Merck & Co., Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Merck & Co., Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Merck & Co. (or 'the company'), known as Merck Sharp & Dohme (MSD) outside the US and Canada, is one of the leading healthcare companies in the world. The company is engaged in the research, development, manufacture and marketing of prescription pharmaceuticals, vaccines, biologic therapies, and consumer care and animal health products. It is headquartered in Whitehouse Station, New Jersey, and employed about 76,000 people as of December 31, 2013. The company recorded revenues of $44,033 million during the financial year ended December 2013 (FY2013), a decrease of 6.8% over FY2012. The operating profit of the company was $5,956 million in FY2013, a decrease of 35.4% over FY2012. The net profit attributable to the company was $4,404 million in FY2013, a decrease of 28.6% over FY2012. In October 2014, Merck & Co. completed the sale of the Merck Consumer Care (MCC) business to Bayer AG for $14.2 billion. Reasons to Purchase: - Gain understanding of Merck & Co., Inc. and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Merck & Co., Inc. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Merck & Co., Inc.’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.